Article: S Black has produced REGU[TM]-SEB, a new formulation designed to control and reduce sebum production in skin that is prone to oiliness.(Brief Article)

Article: Use of intradermal botulinum toxin to reduce sebum ...
Journal of Drugs in Dermatology;  September 1, 2008 ;     700+ words ... ... toxin type A in facial pore size and sebum production. Design: Retrospective analysis ... 17/20) noted an improvement in sebum production and a decrease in pores size at 1 ... toxin may play a role in decreasing sebum production. Further quantitive study may be ...

Article: Patent No. 7,615,230 Issued on Nov. 10, Assigned to Graceway ...
US Fed News Service, Including US State News;  November 11, 2009 ;     415 words ... ... Catherine R. Kostlan of Saline, Mich., and Kimberly Wade of Brighton, Mich., have developed a method for decreasing sebum production. The inventors were issued U.S. Patent No. 7,615,230 on Nov. 10. The patent has been assigned to Graceway Pharmaceuticals ...

Article: Results From IMPROVE Study Show Therapeutic Effect of New ...
PR Newswire Europe;  September 22, 2008 ;     700+ words ... ... Demonstrating Significant Effect of new Formulation of Rebif(R) on Disease Activity ... was to evaluate the efficacy of the new formulation of Rebif(R), compared to placebo ... 69% in patients treated with the new formulation of Rebif(R) compared with those ...

Article: New Formulation of Multiple Sclerosis Treatment ...
PR Newswire Europe;  August 30, 2007 ;     700+ words ... ... Switzerland, August 30 /PRNewswire/ -- - New Formulation of Rebif(R) Designed to Improve ... granted a marketing authorization for a new formulation of Rebif(R) (interferon beta ... relapsing multiple sclerosis (MS). The new formulation of Rebif(R) has been developed ...

Article: One-year Data From Phase III Trial Show That New ...
PR Newswire;  September 28, 2006 ;     700+ words ... ... weeks) Phase IIIb trial show that the new formulation of Rebif(R) (interferon beta ... investigator of the trial. "If approved the new formulation of Rebif(R) potentially represents ... injection site reactions with the new formulation of Rebif(R) at 48 weeks was nearly ...

Article: InKine Announces FDA Approval of "New Formulation" ...
Business Wire;  March 14, 2002 ;     700+ words ... ... drug application (SNDA) for the "new formulation" of Visicol(TM) tablets. InKine ... presented to demonstrate that the new formulation of Visicol was safe and effective ... supplement, which demonstrated that the new formulation provided excellent cleansing prior ...

Article: Serono Submits New Formulation of Rebif(R) for ...
PR Newswire;  April 4, 2006 ;     700+ words ...Trial Data Show New Formulation of Rebif(R) Offers Substantial ... Medicines Agency (EMEA) for a new formulation of Rebif(R) (interferon beta ... relapsing forms of MS show that the new formulation of Rebif(R) results in a substantial ...